Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages 494-503

  Fowble, Barbara L ^a   Einck, John P ^b   Kim, Danny N ^c   McCloskey, Susan ^d   Mayadev, Jyoti ^e   Yashar, Catheryn ^b   Chen, Steven L ^e   Hwang, E Shelley ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Athena Breast Health Network and UCSF Cancer Risk Program   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Postmastectomy radiation

Indexed keywords

AMERICAN COLLEGE OF RADIOLOGIES; BREAST CANCER; COCHRANE DATABASE; DISEASE FREE SURVIVAL; HEALTH NETWORKS; LIMITED DATA; LYMPHOVASCULAR INVASIONS; MEDLINE; OVERALL SURVIVAL; PATHOLOGIC COMPLETE RESPONSE; POSTMASTECTOMY RADIATION THERAPIES; RANDOMIZED TRIAL; RISK CATEGORIES; UNIVERSITY OF CALIFORNIA;

CHEMOTHERAPY; DISEASES; PATHOLOGY; RADIOLOGY; RADIOTHERAPY; RISK PERCEPTION;

HEALTH RISKS;

ANTHRACYCLINE; CISPLATIN; DOXORUBICIN; ESTROGEN RECEPTOR; METHOTREXATE; PLATINUM; TAXANE DERIVATIVE; TRASTUZUMAB; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COCHRANE LIBRARY; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LOW RISK POPULATION; MASTECTOMY; MEDICAL LITERATURE; MEDLINE; OVERALL SURVIVAL; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; UNITED STATES;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CALIFORNIA; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DELPHI TECHNIQUE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LYMPH NODES; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RADIATION ONCOLOGY; RISK ASSESSMENT; TUMOR BURDEN;

EID: 84861032057     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.068     Document Type: Review

References (46)

1. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106 (Pubitemid 41797643)
2. P. Truong, I. Olivotto, and T. Whelan Clinical practice guidelines for the care and treatment of breast cancer: 16 Locoregional post-mastectomy radiotherapy Can Med Assoc J 170 2004 1263 1273 (Pubitemid 38553313)
3. A. Recht, S.B. Edge, and L.J. Solin Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 2001 1539 1569 (Pubitemid 32203717)
4. M.E. Taylor, B.G. Haffty, and R. Rabinovitch ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast Int J Radiat Oncol Biol Phys 73 2009 997 1002
5. A. Goldhirsch, J.N. Ingle, and R.D. Gelber Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 Ann Oncol 20 2009 1319 1329
6. R.W. Carlson, D.C. Allred, and B.O. Anderson Breast cancer. Clinical practice guidelines in oncology J Natl Compr Canc Netw 7 2009 122 192
7. National Institute for Health and Clinical Excellence Early and advanced breast cancer: diagnosis and treatment. NICE clinical guideline. NICE guideline 80 2009 NICE London 75
8. P.N. Cascade, and S.A. Leibel Decision-making in radiotherapy for the cancer patient: the American College of Radiology Appropriateness Criteria Project CA Cancer J Clin 48 1998 146 150 (Pubitemid 28383260)
9. R. Boulkedid, H. Abdoul, and M. Loustau Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review PloS One 6 2011 e20476
10. M. Abdel-Wahab, A. Wolfson, and W. Raub The importance of postoperative radiation therapy in multimodality management of locally advanced breast cancer: a phase II trial of neoadjuvant MVAC, surgery, and radiation Int J Radiat Oncol Biol Phys 40 1998 875 880 (Pubitemid 28150806)
11. A.K. Garg, J.L. Oh, and M.J. Oswald Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy Int J Radiat Oncol Biol Phys 69 2007 1478 1483 (Pubitemid 350116410)
12. T.A. Buchholz, A. Katz, and E.A. Strom Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy Int J Radiat Oncol Biol Phys 53 2002 880 888 (Pubitemid 34722632)
13. T.A. Buchholz, S.L. Tucker, and L. Masullo Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation J Clin Oncol 20 2002 17 23 (Pubitemid 34032591)
14. T.A. Buchholz, E.H. Huang, and D. Berry Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy Int J Radiat Oncol Biol Phys 59 2004 1337 1342 (Pubitemid 38954055)
15. A.K. Garg, E.A. Strom, and M.D. McNeese T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy Int J Radiat Oncol Biol Phys 59 2004 138 145 (Pubitemid 38501517)
16. E.H. Huang, S.L. Tucker, and E.A. Strom Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy J Clin Oncol 22 2004 4691 4699
17. E.H. Huang, S.L. Tucker, and E.A. Strom Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy Int J Radiat Oncol Biol Phys 62 2005 351 357 (Pubitemid 40704449)
18. S.E. McGuire, A.M. Gonzalez-Angulo, and E.H. Huang Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy Int J Radiat Oncol Biol Phys 68 2007 1004 1009 (Pubitemid 47048565)
19. J.L. Oh, M.J. Dryden, and W.A. Woodward Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy J Clin Oncol 24 2006 4971-2975
20. C. Daveau, D. Stevens, and E. Brain Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy? Int J Radiat Oncol Biol Phys 78 2010 337 342
21. O. Gilliot, X. Durando, and C. Abrial Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer? Cancer Invest 28 2010 195 200
22. B. Keam, S.A. Im, and H.J. Kim Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Breast Cancer Res Treat 116 2009 153 160
23. Y.J. Zhang, J. Oh, and G.J. Whitman Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control Int J Radiat Oncol Biol Phys 77 2010 1113 1119
24. R. Le Scodan, J. Selz, and D. Stevens Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy Int J Radiat Oncol Biol Phys 82 2012 e1 e7
25. H. Nagar, E.A. Mittendorf, and E. Strom Local-regional recurrence with and without radiation after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer patients Int J Radiat Oncol Biol Phys 81 2011 782 787
26. th ed. 2010 Lippincott, Williams and Wilkins Philadelphia 730 744
27. T.A. Buchholz, C. Lehman, and J. Harris Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute Conference J Clin Oncol 26 2008 791 797 (Pubitemid 351265334)
28. J.L. Wright, I. Reis, and W. Zhao Relationship between nodal stage, post mastectomy radiation field selection and clinical outcome after neoadjuvant chemotherapy for breast cancer [abstract] Int J Radiat Oncol Biol Phys 78 2010 S97
29. Mamounas E, Anderson S, Bear HD, et al. Predictors of locoregional failure in patients receiving neoadjuvant chemotherapy: results from the combined analysis of NSABP B-18 and NSABP B-27 [abstract]. Presented at the American Society of Clinical Oncology 2010 Breast Cancer Symposium, October 1-3, 2010, National Harbor, MD.
30. S. Settle, A.M. Gonzalez-Angulo, and T.A. Buchholz Locoregional outcomes and radiotherapy response in patients with triple negative breast cancer [abstract] Int J Radiat Oncol Biol Phys 75 2009 S9 S10
31. T. Yu, E.A. Mittendorf, and H. Nagar Local-regional recurrences with and without radiation after neoadjuvant chemotherapy and mastectomy for T1-2/N0-1 breast cancer patients [abstract] Int J Radiat Oncol Biol Phys 72 2008 S88 S89
32. C. Fasola, K. Godette, and M.W. McDonald The effect of radiotherapy on local regional recurrence among patients with pathologic complete response to neoadjuvant chemotherapy in breast cancer [abstract] Int J Radiat Oncol Biol Phys 78 2010 S96
33. T.K. Poonacha, and R.S. Go Level of scientific evidence underlying recommendations arising from the national comprehensive cancer network clinical practice guidelines J Clin Oncol 29 2011 186 191
34. I.A. Olivotto, P.T. Truong, and B. Chua Postmastectomy radiation therapy: who needs it? J Clin Oncol 22 2004 4237 4239 (Pubitemid 41185142)
35. M.E. Straver, E.J. Rutgers, and S. Rodenhuis The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy Ann Surg Oncol 17 2010 2411 2418
36. C. Liedtke, C. Mazouni, and K.R. Hess Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 2008 1275 1281
37. R. Bhargava, S. Beriwal, and D.J. Dabbs Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases Cancer 116 2010 1431 1439
38. W.F. Symmans, F. Peintinger, and C. Hatzis Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy J Clin Oncol 25 2007 4414 4422 (Pubitemid 350013847)
39. K. Hoffman, W.F. Symmans, and J. Oh Pathologic features predicting for high rates of local-regional recurrence after neoadjuvant chemotherapy and radiation for breast cancer [abstract] Int J Radiat Oncol Biol Phys 78 2010 S97
40. Partin J, Mamounas E, Nelson K, et-al. Impact of the 21-gene recurrence score assay compared with guidelines based on clinicopathologic criteria on adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer [abstract]. Presented at the 2010 American Society of Clinical Oncology Breast Cancer Symposium, October 1-3, 2010, National Harbor, MD.
41. E. Mamounas, G. Tang, and B. Fisher Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node negative, estrogen receptor-positive breast cancer: results from the NSABP B-14 and NSABP B-20 J Clin Oncol 28 2010 1677 1683
42. P.T. Truong, C.M. Yong, and F. Abnousi Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy J Am Coll Surg 200 2005 912 921 (Pubitemid 40744800)
43. R. Jagsi, R.A. Raad, and S. Goldberg Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation Int J Radiat Oncol Biol Phys 62 2005 1035 1039 (Pubitemid 40884415)
44. R. Sharma, I. Bedrosian, and A. Lucci Present-day locoregional control in patients with T1 or T2 breast cancer with 0-3 positive lymph nodes after mastectomy without radiotherapy Ann Surg Oncol 17 2010 2899 2908
45. S.M. MacDonald, R.F. Abi-Raad, and M. Alm El-Din Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy Int J Radiat Oncol Biol Phys 75 2009 1297 1303
46. P.T. Truong, I.A. Olivotto, and H.A. Kader Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy Int J Radiat Oncol Biol Phys 61 2005 1337 1347 (Pubitemid 40470413)